The Angel in the Marble: Antibiotic Duration in the Neonatal Intensive Care Unit

Joseph B Cantey1, Dalyn B Guinn2

  • 1Department of Pediatrics, Divisions of Neonatology and Immunology & Infectious Diseases, University of Texas Health San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78232, USA.

PubMed

Insights

Optimizing antimicrobial stewardship in neonatal intensive care units (NICUs) is crucial. This review examines antibiotic treatment durations for infants, identifying knowledge gaps and proposing safer, shorter treatment strategies.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Antimicrobial stewardship is vital for optimizing clinical outcomes in neonatal intensive care units (NICUs).
  • Significant knowledge gaps exist regarding the ideal duration of antimicrobial therapy for neonates.
  • Current practices require evidence-based guidelines for antibiotic use in this vulnerable population.

Purpose of the Study:

  • To review existing evidence on empiric and definitive antibiotic treatment durations for infants.
  • To identify clinical scenarios necessitating further research in neonatal antibiotic therapy.
  • To propose a goal-based framework for clinical studies investigating shorter antibiotic durations while ensuring infant safety.

Main Methods:

  • This study is a narrative review of existing literature.
  • It synthesizes evidence on antibiotic treatment durations for neonatal infections.
  • It focuses on identifying research gaps and proposing future study designs.

Main Results:

  • The review highlights variability in current antibiotic treatment durations for neonatal infections.
  • Specific clinical situations requiring further investigation are identified.
  • A need for evidence-based, shorter treatment durations is emphasized.

Conclusions:

  • Further research is essential to establish optimal, evidence-based antibiotic treatment durations for neonates.
  • A rational, goal-based approach to clinical studies is proposed to ensure infant safety during de-escalation of antibiotic therapy.
  • Optimizing antimicrobial stewardship through refined treatment durations can improve neonatal outcomes.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
50
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
532
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
688
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
368